Phathom Pharmaceuticals Inc’s recent filing unveils that its Principal Accounting Officer Breedlove Robert Charles unloaded Company’s shares for reported $14152.0 on Jul 16 ’25. In the deal valued at $8.36 per share,1,692 shares were sold. As a result of this transaction, Breedlove Robert Charles now holds 48,392 shares worth roughly $0.38 million.
Then, Topper James N bought 3,780 shares, generating $14,609 in total proceeds. Upon buying the shares at $3.86, the Director now owns 59,403 shares.
Before that, Topper James N bought 6,300 shares. Phathom Pharmaceuticals Inc shares valued at $20,919 were divested by the Director at a price of $3.32 per share. As a result of the transaction, Topper James N now holds 55,623 shares, worth roughly $0.44 million.
Cantor Fitzgerald initiated its Phathom Pharmaceuticals Inc [PHAT] rating to an Overweight in a research note published on February 14, 2025; the price target was $23. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. Needham also remained covering PHAT and reiterated its “Buy” recommendation on January 05, 2024. H.C. Wainwright started covering the stock on August 09, 2023. It rated PHAT as “a Buy”.
Price Performance Review of PHAT
On Friday, Phathom Pharmaceuticals Inc [NASDAQ:PHAT] saw its stock fall -4.45% to $7.95. Over the last five days, the stock has lost -13.40%. Phathom Pharmaceuticals Inc shares have fallen nearly -34.94% since the year began. Nevertheless, the stocks have fallen -2.09% over the past one year. While a 52-week high of $19.71 was reached on 06/06/25, a 52-week low of $2.21 was recorded on 05/08/25.
Levels Of Support And Resistance For PHAT Stock
The 24-hour chart illustrates a support level at 7.73, which if violated will result in even more drops to 7.50. On the upside, there is a resistance level at 8.36. A further resistance level may holdings at 8.76.
How much short interest is there in Phathom Pharmaceuticals Inc?
A steep rise in short interest was recorded in Phathom Pharmaceuticals Inc stocks on 2025-06-13, dropping by -0.14 million shares to a total of 11.04 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 11.18 million shares. There was a decline of -1.26%, which implies that there is a negative sentiment for the stock.
